Recent discussions on X about Bausch Health Companies (BHC) have been buzzing with activity following a significant insider purchase by a director, who reportedly acquired millions of shares at varying prices over the past few days. Many users are interpreting this as a strong signal of confidence in the company's future, especially amidst its recent stock price rebound of over 15% after a strong Q2 earnings report. The acquisition of DURECT Corporation for $63 million has also fueled conversations about potential growth in the liver disease treatment sector.
Additionally, posts on X highlight the company's raised guidance for 2025, with some users speculating on whether this momentum can be sustained given past volatility in the stock. The tone of these discussions often reflects optimism, though there are occasional notes of caution about the company's historical debt challenges. This mix of excitement and scrutiny keeps the dialogue around BHC dynamic and engaging.
Note: This discussion summary was generated from an AI condensation of post data.
Bausch Health Companies Insider Trading Activity
Bausch Health Companies insiders have traded $BHC stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BHC stock by insiders over the last 6 months:
- JOHN PAULSON has made 8 purchases buying 44,316,834 shares for an estimated $369,628,560 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Bausch Health Companies Hedge Fund Activity
We have seen 87 institutional investors add shares of Bausch Health Companies stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NOMURA HOLDINGS INC added 12,050,000 shares (+106.2%) to their portfolio in Q1 2025, for an estimated $77,963,500
- MIZUHO MARKETS AMERICAS LLC removed 7,000,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $45,290,000
- PAULSON & CO. INC. added 6,352,667 shares (+24.0%) to their portfolio in Q2 2025, for an estimated $42,308,762
- GOLDENTREE ASSET MANAGEMENT LP added 4,004,889 shares (+13.2%) to their portfolio in Q2 2025, for an estimated $26,672,560
- CITADEL ADVISORS LLC removed 3,942,460 shares (-75.8%) from their portfolio in Q1 2025, for an estimated $25,507,716
- MUFG SECURITIES EMEA PLC added 3,400,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $22,644,000
- SG AMERICAS SECURITIES, LLC added 3,282,684 shares (+114.4%) to their portfolio in Q2 2025, for an estimated $21,862,675
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
